Loading patent…
AssigneeAffinium Pharmaceuticals, Inc.
InventorsMichael Black, Martin Burnham, Jason Fedon, John Hodgson, David Knowles, Michael Lonetto, Richard Nicholas, Leslie Palmer, Julie Pratt, Raymond Reichard, Martin Rosenberg, Christopher Traini, Judith Ward, Richard Warren
Estimating the term…
This invention relates to newly identified Staphylococcal polynucleotides, polypeptides encoded by such polynucleotides, the uses of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides and recombinant host cells transformed with the polynucleotides. This invention also relates to inhibiting the biosynthesis or action of such polynucleotides or polypeptides and to the use of such inhibitors in therapy.
An isolated polypeptide comprising SEQ ID NO:
An isolated nucleic acid comprising SEQ ID NO:
An isolated nucleic acid consisting of SEQ ID NO:
A vector comprising the isolated polynucleotide of claim 12.
An isolated nucleic acid molecule which specifically hybridizes under stringent conditions to SEQ ID NO:
Dependencies are inferred from the claim text.